Bayesian Health's FDA-Cleared Continuous AI Sepsis Monitor Approved for Medicare New Technology Add-on Payment (NTAP)

Beginning October 1, 2026, hospitals using Bayesian's continuous sepsis monitor can receive additional Medicare reimbursement for eligible inpatient cases, the first reimbursement pathway of its kind for presuspicion sepsis monitoring. NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Bayesian...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.